TRIM56 Aggravates Cerebral Ischemia‐Reperfusion Injury via Inhibiting KLF4‐Activated Ferroptosis Signaling
Advanced Science · 2026-02 · 13 (8)
DOI: 10.1002/advs.202509906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 10.11.2025. Verfasst von Qiangping Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Ferroptosis, Kruppel-Like Transcription Factors, Tripartite Motif Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Ganzhou Science and Technology Innovation Talent Project - Youth Talent Project.
Abstract (Originalsprache)
Cerebral ischemia‐reperfusion (I/R) injury often causes significant neuronal damage, neurological deficits, and long‐term disability. This study investigates the role of tripartite motif‐protein 56 (TRIM56) in cerebral I/R injury and elucidates the underlying mechanisms. Here, a significant increase in TRIM56 expression in the human brain, mouse brain, and primary neurons after cerebral I/R injury is first detected. TRIM56 knockout mice exhibit reduced neurological deficits and a diminished inflammatory response, with TRIM56 overexpression intensifying these effects. Mechanistic investigations demonstrate that TRIM56 promotes neuronal ferroptosis by directly interacting with Krüppel‐like factor 4 (KLF4) and triggering its K48‐linked ubiquitination‐dependent degradation. Moreover, compound screening identifies farudodstat as a potential TRIM56 inhibitor to reduce I/R injury in vivo and in vitro. In conclusion, TRIM56 critically regulates neuronal damage during cerebral I/R injury, thereby presenting as a potential therapeutic target for reducing brain I/R injury. Novel therapeutic strategies inhibiting TRIM56 or its downstream signaling pathways may be developed to mitigate the devastating effects of I/R injury on neuronal survival and function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Department of Neurosurgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan, 453100, China.
- Department of Central laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China.
- State Key Laboratory of North China Crop Improvement and Regulation, Hebei Agricultural University, Baoding, Hebei, 071000, China.
- State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, 341000, China.
ORCID-Profile: Haijun Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Ganzhou Science and Technology Innovation Talent Project - Youth Talent Project
Zitieren
APA
Wang, Q., Li, S., Li, M., Zhou, W., Zhang, J., Wu, Z., Mao, Z., Wan, J., Tang, X., Zheng, B., Liu, Q., Li, Z., Jiang, X., Wu, Q., Ye, Y., & Wang, H. (2026). TRIM56 Aggravates Cerebral Ischemia‐Reperfusion Injury via Inhibiting KLF4‐Activated Ferroptosis Signaling. Advanced Science, 13(8). https://doi.org/10.1002/advs.202509906
Vancouver
Wang Q, Li S, Li M, Zhou W, Zhang J, Wu Z, et al. TRIM56 Aggravates Cerebral Ischemia‐Reperfusion Injury via Inhibiting KLF4‐Activated Ferroptosis Signaling. Advanced Science. 2026;13(8). doi:10.1002/advs.202509906
BibTeX
@article{Wang2026,
author = {Wang, Qiangping and Li, Shuang and Li, Man and Zhou, Wenke and Zhang, Jianqing and Wu, Zhenfu and Mao, Zhaoqi and Wan, Juan and Tang, Xinhao and Zheng, Baoping and Liu, Qiang and Li, Zhendong and Jiang, Xiaobing and Wu, Qingping and Ye, Youfan and Wang, Haijun},
title = {TRIM56 Aggravates Cerebral Ischemia‐Reperfusion Injury via Inhibiting KLF4‐Activated Ferroptosis Signaling},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {8},
doi = {10.1002/advs.202509906}
}
EUVIMED